| Literature DB >> 18412193 |
Shinya Oishi1, Ryo Masuda, Barry Evans, Satoshi Ueda, Yukiko Goto, Hiroaki Ohno, Akira Hirasawa, Gozoh Tsujimoto, Zixuan Wang, Stephen C Peiper, Takeshi Naito, Eiichi Kodama, Masao Matsuoka, Nobutaka Fujii.
Abstract
The design, synthesis, and bioevaluation of fluorescence- and biotin-labeled CXCR4 antagonists are described. The modification of D-Lys8 at an epsilon-amino group in the peptide antagonist Ac-TZ14011 derived from polyphemusin II had no significant influence on the potent binding of the peptide to the CXCR4 receptor. The application of the labeled peptides in flow cytometry and confocal microscopy studies demonstrated the selectivity of their binding to the CXCR4 receptor, but not to CXCR7, which was recently reported to be another receptor for stromal cell-derived factor 1 (SDF-1)/CXCL12.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18412193 DOI: 10.1002/cbic.200700761
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164